stars 1 stars 2 stars 3

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper balloon occlusion microcatheter sets a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.

Embolx, Inc. Questions

The Embolx, Inc. annual revenue was $1 million in 2026.

Michael Allen is the President and CEO of Embolx, Inc..

9 people are employed at Embolx, Inc..

Embolx, Inc. is based in Sunnyvale, California.

The NAICS codes for Embolx, Inc. are [33, 339].

The SIC codes for Embolx, Inc. are [38, 384].

Top Embolx, Inc. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users